Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 96

    Dr Reddys launches Sevelamer Carbonate tablets in US

    Dr Reddys launches Sevelamer Carbonate tablets in US

    Ruby Khatun Khatun3 Oct 2017 10:01 AM IST
    HYDERABAD: Dr. Reddy’s Laboratories Ltd has launched Sevelamer Carbonate tablets, 800 mg, a therapeutic equivalent generic version of Renvela...
    Clinical trials in India: Drug Cos to pay 60 percent compensation in 15 days, says Govt

    Clinical trials in India: Drug Cos to pay 60 percent compensation in 15 days, says Govt

    Ruby Khatun Khatun2 Oct 2017 11:01 AM IST
    New Delhi: 60% compensation within a 15-day interval has to be paid by drug companies conducting clinical trials in India, in case a patient on whom...
    Karnataka cabinet approves biotech policy for 2017-22

    Karnataka cabinet approves biotech policy for 2017-22

    Ruby Khatun Khatun2 Oct 2017 10:37 AM IST
    New Delhi: Karnataka Cabinet gave its approval to the state Biotechnology Policy 2017-22 which will give further impetus for the growth of the sector,...
    SMT launches next generation Supralimus Grace drug eluting stent in India

    SMT launches next generation Supralimus Grace drug eluting stent in India

    Ruby Khatun Khatun1 Oct 2017 11:15 AM IST
    Mumbai: SMT, One of the largest stent manufacturing company in India, has recently announced the launch and widespread availability plans for its...
    Great News: Serum Institutes vaccine Rotavirus Gastroenteritis shows efficacy

    Great News: Serum Institutes vaccine Rotavirus Gastroenteritis shows efficacy

    Ruby Khatun Khatun1 Oct 2017 9:17 AM IST
    Pune: Results from a Phase 3 efficacy study in India of the Serum Institute of India Pvt. Ltd.’s rotavirus vaccine BRV-PV (known as ROTASIIL®) were...
    Soon, customised drugs to be printed on site

    Soon, customised drugs to be printed on site

    Ruby Khatun Khatun30 Sept 2017 11:40 AM IST
    Washington: Scientists, including those of Indian origin, have developed a technology that can print pure, ultra-precise doses of drugs onto a wide...
    Pharma companies lag in digital journey against global counterparts: EY

    Pharma companies lag in digital journey against global counterparts: EY

    Ruby Khatun Khatun30 Sept 2017 10:39 AM IST
    MUMBAI: Indian pharmaceutical companies lag behind in their digital journey as compared to their global counterparts, according to an industry...
    Govt asks stent makers to maintain supply of coronary stents

    Govt asks stent makers to maintain supply of coronary stents

    Ruby Khatun Khatun29 Sept 2017 11:30 AM IST
    New Delhi: The government has directed coronary stent makers to maintain the production and supply of stents in the country amid reports of shortage...
    Dr Reddys gets EIR from USFDA for Srikakulam unit

    Dr Reddys gets EIR from USFDA for Srikakulam unit

    Ruby Khatun Khatun29 Sept 2017 10:01 AM IST
    New Delhi: Dr Reddy's Laboratories said it has received an establishment inspection report (EIR) from the US health regulator for a unit at its...
    Concerned about Oxytocin misuse, CDSCO to outline regulatory control

    Concerned about Oxytocin misuse, CDSCO to outline regulatory control

    supriya kashyap kashyap28 Sept 2017 4:41 PM IST
    New Delhi: Concerned about Oxytocin misuse, CDSCO is now going to ensure Strict Regulatory control over Manufacture, sale, and distribution of...
    Dabur plans subscription-based model for ayurvedic medicines

    Dabur plans subscription-based model for ayurvedic medicines

    supriya kashyap kashyap28 Sept 2017 9:07 AM IST
    New Delhi: Homegrown FMCG major Dabur is testing a subscription-based model for its ayurvedic medicines in the country, a senior company official...
    Speciality segment to be a key growth driver for Sun Pharma: Dilip Shanghvi

    Speciality segment to be a key growth driver for Sun Pharma: Dilip Shanghvi

    supriya kashyap kashyap27 Sept 2017 4:10 PM IST
    New Delhi: Drug major Sun Pharmaceutical Industries said it has identified speciality segment as one of the key drivers for growth going forward.The...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Pharma Export do not need NOC: CDSCO

    Pharma Export do not need NOC: CDSCO

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Government of India bans Ofloxacin, Ornidazole injection combination

    Government of India bans Ofloxacin, Ornidazole injection combination

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok